Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomedical patents and ethics: a Canadian solution.

E R Gold1

  • 1Faculty of Law, The University of Western Ontario, Canada.

Mcgill Law Journal. Revue De Droit De Mcgill
|April 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic technologies, health care policy and the patent bargain.

Clinical genetics·2003
Same author

Patenting human genetic material: refocusing the debate.

Nature reviews. Genetics·2001
Same author

Genetic testing, ethical concerns, and the role of patent law.

Clinical genetics·2000
Same author

Short communication structure of 'natural antibodies' in lower vertebrates.

Journal of immunogenetics·1976
Same author

The natural heterohaemagglutinin in the serum of the toad Bufo regularis, and its relationship to lower vertebrate immunoglobulins.

Immunology·1976
Same journal

The legal status of clinical and ethics policies, codes, and guidelines in medical practice and research.

McGill law journal. Revue de droit de McGill·2006
Same journal

Sex and the sacred: sterilization and bodily integrity in English and Canadian law.

McGill law journal. Revue de droit de McGill·2006
Same journal

Selective justice, genetic discrimination, and insurance: should we single out genes in our laws?

McGill law journal. Revue de droit de McGill·2003
Same journal

Reflections: the challenge of biotechnology and public policy.

McGill law journal. Revue de droit de McGill·2003
Same journal

Genetics, parenting, and children's rights in the twenty-first century.

McGill law journal. Revue de droit de McGill·2003
Same journal

Displaced agendas: current regulatory strategies for germline gene therapy.

McGill law journal. Revue de droit de McGill·2003
See all related articles

Canada should leverage its medicare system to address ethical considerations in patenting biomedical materials, promoting discussion and social values. This approach balances innovation incentives with societal well-being while awaiting international consensus.

Area of Science:

  • Biotechnology Law
  • Intellectual Property Rights
  • Bioethics

Background:

  • Upcoming renegotiation of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
  • Ethical considerations surrounding the patenting of higher life forms, DNA, and cell-lines are critical.
  • The intersection of genetic advancements, patentability, and ethical frameworks requires careful examination.

Purpose of the Study:

  • To explore and critique four potential policy positions for Canada regarding the patentability of biomedical materials.
  • To analyze the ethical and social implications of different patenting approaches.
  • To propose a framework for Canada's stance on intellectual property for biomedical innovations.

Main Methods:

  • Analysis of four distinct policy options for Canada.
Keywords:
Biomedical and Behavioral ResearchGenetics and ReproductionLegal Approach

Related Experiment Videos

  • Critique of each option based on ethical, social, and economic considerations.
  • Proposal of a model for patenting biomedical materials involving non-profit entities.

    • Main Results:

    • Option 1: Do nothing (wait for international consensus).
    • Option 2: Go it alone (balance incentives with ethics, using non-profits).
    • Option 3: Unrestricted patenting (industry-friendly).
    • Option 4: Utilize the medicare system to foster ethical discussions.

    Conclusions:

    • The fourth option, using the medicare system to promote ethical discussions, is the most suitable for Canada.
    • This approach allows for the integration of ethical and social values into the patenting debate.
    • It provides a proactive strategy while awaiting global consensus on biomedical material patenting.